Resonance Health attended and exhibited at the American Association for the Study of Liver Disease (AASLD) conference in Boston on the 7-11 November.
Resonance Health tackles growing prevalence of fatty liver disease and is awarded the 2014 WA Innovator of the Year Overall Winner for HepaFat-Scan
Resonance Health is excited to be exhibiting at the Annual Meeting of the British Association for the Study of the Liver in England this week – 14th – 18th September 2014.
Resonance Health has provided this website to deliver general information. Resonance Health Limited and its subsidiary companies including its officers, employees, representatives and consultants use all reasonable efforts to include up-to-date, complete and accurate information in this website. Resonance Health is not responsible for any error, omission, misrepresentation, or misstatement contained in these pages and